LOXO-292, which selectively targets RET and has demonstrated preclinical activity against activating RET fusions/mutations, holds promise.
A study shows thalidomide-based treatment carries risk, but could be an option for certain multiple myeloma patients.
Radioguided surgery using gallium 68 dota peptides offers a highly sensitive method for detecting neuroendocrine tumors.
FDA approves once-weekly carfilzomib/dexamethasone combo for relapsed or refractory multiple myeloma.
In a first-of-its-kind study, researchers analyzed how Twitter users talk about breast cancer on the social media platform.
A study shows ZEB2 has clinical potential and may improve TNM risk-stratification and guide treatment in colorectal cancer.
We take a look at how a healthy diet can improve quality of life in breast cancer survivors.
A study of an equal-access military health system shows universal health insurance for both the military and civilian populations could improve CRC screening rates.
Cemiplimab (Libtayo), approved for advanced cutaneous squamous cell carcinoma, is intended for those not eligible for curative surgery or radiation.
A study shows NSCLC patients who undergo minimally invasive procedures are less likely to use opioids long-term.